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Abstract 
Background: Health research governance is an essential function of national health research systems. Yet many Afri‑
can countries have not developed strong health research governance structures and processes. This paper presents a 
comparative analysis of national health research governance in Botswana, Kenya, Uganda and Zambia, where health 
sciences research production is well established relative to some others in the region and continues to grow. The 
paper aims to examine progress made and challenges faced in strengthening health research governance in these 
countries.
Methods: We collected data through document review and key informant interviews with a total of 80 participants 
including decision‑makers, researchers and funders across stakeholder institutions in the four countries. Data on 
health research governance were thematically coded for policies, legislation, regulation and institutions and analysed 
comparatively across the four national health research systems.
Results: All countries were found to be moving from using a research governance framework set by national science, 
technology and innovation policies to one that is more anchored in health research structures and policies within the 
health sectors. Kenya and Zambia have adopted health research legislation and policies, while Botswana and Uganda 
are in the process of developing the same. National‑level health research coordination and regulation is hampered 
by inadequate financial and human resource capacities, which present challenges for building strong health research 
governance institutions.
Conclusion: Building health research governance as a key pillar of national health research systems involves devel‑
oping stronger governance institutions, strengthening health research legislation, increasing financing for govern‑
ance processes and improving human resource capacity in health research governance and management.
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Background
Research governance has been described as an over-
arching responsibility of government to ensure effective 
oversight, coalition-building, system design, account-
ability and regulation of research for health in both the 
public and private sectors [1]. The WHO Regional Office 
for Africa (WHO AFRO) identifies research governance 
as a core function of a national health research system 
(NHRS), alongside developing and sustaining resources, 
financing, and producing and using research [1, 2]. The 
World health report 2013 emphasizes that every country 
needs to have an effective NHRS to set research priori-
ties, develop research capacity, define norms and stand-
ards for research, and translate evidence into practice [3]. 
In Africa, strengthening NHRS is particularly essential to 
generate research that would inform interventions as well 
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Past initiatives to improve NHRS in African coun-
tries have generally focused on strengthening govern-
ance mechanisms, capacity-building and funding [5–8]. 
These are frequently short-term initiatives, lacking sus-
tained engagement and support. Studies have shown 
that challenges in health research governance for Afri-
can countries include inadequate funding for govern-
ance activities, misalignment of research funding with 
national research priorities, lack of optimal coordination 
among stakeholders and limited health research capacity 
[6, 9, 10].
Strengthening national health research governance is a 
long-term investment that requires political commitment 
and sustainable action, which includes public institutions 
and policies to regulate and coordinate research institu-
tions and research conduct. Robust and high-performing 
NHRS have typically integrated governance elements 
such as national research policies and regulations, insti-
tutional structures and systems to guide and support 
researchers, and funding mechanisms [11]. However, 
many low- and middle-income countries have histori-
cally faced challenges in the development of research 
governance and management of these elements [9]. This 
has been attributed to several factors, such as models of 
research capacity-building that focus primarily on devel-
oping individual skills without the necessary national 
and institutional structures and systems to support the 
trained individuals, or inadequate funding for research 
systems strengthening [12, 13].
Several frameworks have been developed to support 
the design and evaluation of health research governance 
for NHRS, for research institutions, or for health research 
funding institutions. The frameworks of Pang et al. [14], 
WHO’s AFRO NHRS barometer [1] and the Council on 
Health Research for Development (COHRED) [15] are 
oriented around needs at the national systems level, to 
describe and guide the governance of NHRS. Smits and 
Champagne [16], on the other hand, provide a framework 
adapted for the governance needs of health research 
funding institutions. Unlike the other three frameworks, 
which address activities and roles for health research gov-
ernance, the WHO AFRO NHRS barometer [1] provides 
a list of the types of policies and structures that should be 
in place for health research governance. Table 1 summa-
rizes key features of these frameworks related to govern-
ance functions.
Looking across these frameworks, some common gov-
ernance functions can be identified, including policies 
and legislation, strategic vision and planning, prioritiza-
tion, coordination, management, and ethical regulation. 
The Smits and Champagne framework was the only one 
to include accountability and resourcing within govern-
ance functions, perhaps related to its intended use by 
research funding agencies. The Pang et al. framework is 
the only one to explicitly include monitoring and evalu-
ation of the NHRS as governance functions, although 
this is implicit in the COHRED and Smits and Cham-
pagne frameworks embedded in management and system 
optimization.
According to the latest review of NHRS in sub-Saha-
ran Africa using the WHO AFRO NHRS barometer 
published in 2019, African countries have made some 
progress on health research governance indicators in 
the 5  years since the previous assessment [2]. More 
recently, results from a survey of WHO AFRO Member 
States specifically reported on which countries have the 
health research governance structures in place that are 
recommended by the WHO AFRO regional strategy on 
research for health with data from 35/47 countries [17, 
18]. Neither of these studies, however, provides analysis 
of how governance arrangements function to support 
NHRS at a national level.
Indeed, despite the existence of these frameworks and 
WHO’s NHRS barometer, there have been limited studies 
of national health research governance in African coun-
tries. Sombié et  al. present one example of this, how-
ever, providing insights on how the West African Health 
Organization’s (WAHO) collaboration with COHRED 
helped to strengthen health research governance and 
management mechanisms in four West African coun-
tries [8]. While health research governance is generally 
the ministry of health’s responsibility in three of the four 
countries involved in that study, there was limited capac-
ity for this within the health sector. None of the countries 
had research coordination mechanisms. Sombié et  al. 
[8] found that improvements in areas of governance (e.g. 
policy development, ethics committees and training, 
stakeholder mapping, and health research monitoring 
systems) were made thanks to the participatory design 
of the project, with each country working on their own 
priorities defined by them and the shared learning across 
the implementing teams. The leadership role of a regional 
organization like WAHO with strong presence and net-
works in the countries was also a supporting factor for 
collaboration on health research governance in the coun-
tries, although changes in other aspects of NHRS—such 
as funding, human resources and research use—were 
highlighted as needing more long-term engagement and 
context-specific action from local leadership.
Other work has been done at the organizational level, 
such as studies that look at research governance in 
research institutions and universities [12, 19, 20]. These 
studies have examined governance elements such as the 
presence of institutional research policies, strengthening 
research management offices and the development of eth-
ics review systems as important functions of governance, 
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or they have focused on specific research areas, such as 
governance of clinical trials and mental health research 
[21]. The studies have found some improvements in 
strengthening of ethics regulatory systems in the African 
countries, for example through collaborations with sup-
port from international partners [19].
Given the fairly limited literature exploring national 
governance for health research systems, this paper aims 
to analyse and compare health research governance 
functions in a set of four African countries—Botswana, 
Kenya, Uganda and Zambia. It further explores what 
has supported or challenged the strengthening of health 
research governance, and stakeholder perspectives on 
why key functions are important for the governance of 
NHRS in these countries.
Country background
We selected the four cases from a larger research pro-
ject examining health sciences research (HSciR) capacity 
across the African continent [22]. These four countries 
are all anglophone former British colonies, which would 
indicate some potential shared institutional structures 
and governance. It has been noted that many research 
institutions were established by the colonial authorities 
to provide information needed for further exploration 
and settlement [23]. Yet the countries also have unique 
features in relation to their history of research and post-
colonial experiences. For example, Uganda was home to 
one of the highest regarded African universities at inde-
pendence, with Makerere University called “Africa’s Har-
vard” by some [24]—but post-independence civil conflict 
and authoritarian regimes dramatically impacted the sec-
tor before it could recover from the late 1980s onwards 
[25]. Kenya on the other hand developed its medical 
school later than Uganda [23], but established a number 
of new research institutes over time, including the Kenya 
Medical Research Institute (KEMRI) in 1979 which has 
grown to be a globally regarded research centre [26].
Acknowledging the different histories of research 
institutions in these countries, the current institutional 
Table 1 Key concepts from health research governance frameworks
Framework Scope Functions Core elements of health research 
governance
COHRED Guide to developing and 
managing effective health research 
systems [15]
National health research systems 
and health research institutions
‑ Governance and management Policies, priorities and management
‑ Conducive environment and leader‑
ship
‑ Ability to optimize resources and 
international integration
‑ Formalized partnership arrangements
‑ Ethical regulation
‑ Coordination
Smits and Champagne Framework on 
governance of health research [16]
Health research funding institutions ‑ Governance ‑ Accountability and performance
‑ Strategy formulation
‑ Resourcing and instrumentation
‑ Intelligence acquisition
‑ Relationship management
Pang et al. Conceptual Framework for 
health research systems [14]
National health research systems ‑ Stewardship ‑ Define and articulate of a vision for 
a NHRS
‑ Identify appropriate health research 
priorities and coordinate adherence 
to them
‑ Set and monitor ethical standards for 
health research and research partner‑
ships
‑ Monitor and evaluate the NHRS
WHO AFRO NHRS barometer [1] National health research systems ‑ Indicators of governance ‑ National health policy
‑ National strategic health plan
‑ National health research policy and 
strategic health research plan
‑ Health research law
‑ National health research manage‑
ment forum
‑ National health research priority 
agenda
‑ Scientific review committee
‑ National health ethics review com‑
mittee
‑ Hospital ethics review committees
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landscape of research institutions is also relevant to the 
exploration of governance functions, because they are the 
settings for the training and conduct of HSciR. Table  2 
lists the main public and private research institutions, 
universities and centres of excellence for health research 
in each country that we have inventoried through docu-
ment analysis and from discussions with key stakehold-
ers. Whilst this was not a product of a systematic exercise 
and may not be comprehensive, the list resembles the 
research institution landscape (for health) inventoried 
in grey literature (see https:// www. commo nweal thofn 
ations. org /-Sectors->Country->Education->Research 
Institutes). Although there is variation in the numbers 
and types of research institutions, public universities 
conduct health research in all four countries, and in some 
instances the universities have also established autono-
mous research institutes through international collabo-
rations. Specialized research institutes and centres of 
excellence, particularly in areas of infectious diseases, 
also constitute important knowledge producers in the 
institutional landscape.
Although some states are members of the same 
regional blocks and research hubs, they perform dif-
ferently according to standardized metrics of national 
research performance and capacity. That said, they all 
have reasonably well-established health research activi-
ties and infrastructures compared to some other coun-
tries in the region. Acknowledging that Kenya and 
Uganda have a much larger population than Botswana 
and Zambia, there are similarities and differences in 
generally accepted per capita indicators of HSciR per-
formance (see Table  3). These indicators were collected 
within our larger project that searched for comparable 
data on HSciR capacity and performance across Africa 
[see Wenham et  al. [27] (In Press) for greater detail on 
these indicators and Mijumbi et  al. [28] for a critical 
reflection on their use and limitations].
Botswana and Kenyan authors are named in more 
publications (where any author comes from the coun-
try) and first-authored publications on health per 
million inhabitants, relative to those of Uganda and 
Table 2 Main health research institutions, universities and 
centres of excellence
Botswana Botswana International University of Science and Technology
The Botswana Harvard AIDS Institute
Botswana‑UPenn Partnership (BUP)
Botswana Vaccine Institute
National centre of excellence on infectious diseases
University of Botswana
WHO Collaborating Centre for Nursing and Midwifery Devel‑
opment
Kenya Academic Model Providing Access to Healthcare (AMPATH)
Alupe Leprosy and Other Skin Diseases Research Centre
The Centre for HIV and AIDS Prevention and Research 
(CHIVPR)
East African Kidney Institute (EAKI)
Institute of Tropical and Infectious Diseases (UNITID)
Kenya Institute for Public Policy Research and Analysis (KIP‑
PRA)
Kenya Medical Research Institute (KEMRI)
Trypanosomiasis Research Centre (KARI‑TRC)
University of Nairobi, College of Health Sciences
Uganda Clarke International University
Gulu University
Infectious Diseases Institute (IDI)
Kampala International University Natural Chemotherapeutics 
Research Laboratory
Makerere University
Makerere University Walter Reed Project (MUWRP)
Mbarara University of Science and Technology
Nkozi University
Uganda Industrial Research Institute
Uganda Virus Research Institute
Zambia Centre for Infectious Disease Research
Macha Malaria Research Institute
Tropical Diseases Research Centre
University of Zambia
Table 3 Selected indicators of HSciR performance
a  World Bank. Data from 2016 b Scopus (data publications published between 2008 and 2018) and SciVal (data from 2013 to 2017) c WHO International Clinical 
Trials Registry Platform and United States National Institutes of Health clinical trials database. Data from 2018 d United Nations Educational, Scientific and Cultural 
Organization Institute for Statistics (category: science, technology and innovation). Data from most recent available year between 2005 and 2016
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Botswana 15,581 2250 6924 784.80 335.96 41.33 0.53728 86.56169 570
Kenya 70,529 48,462 1455 294.79 125.27 13.19 0.78578 19.06104 1029
Uganda 24,079 41,488 580 198.85 84.27 15.69 0.17043 2.93947 42
Zambia 21,064 16,591 1270 166.23 51.89 15.79 0.27819 7.7016 163
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Zambia (with first-author position seen as one poten-
tial proxy for research leadership). Botswana and Kenya 
also spend more on research and development (as a 
percentage of GDP and per capita) in general (gross 
expenditure on research and development [GERD] data 
were not specific to health). Botswana also has a nota-
bly higher number of clinical trials per million inhabit-
ants than the other countries, supported by the strong 
history of HIV/AIDS research collaborations since the 
early days of the epidemic. While these indicators pro-
vide a static snapshot of the state inputs and outputs 
for HSciR in the four countries, they do not capture 
the dynamic processes at play behind these metrics, 
or the research governance underpinning knowledge 
production.
While Kenya and Uganda have similar health research 
and development portfolios, Zambia and Botswana are 
considered to have smaller portfolios mainly focused on 
clinical trials for infectious diseases [29]. As researchers 
in institutions from all four countries rely on interna-
tional funding institutions to support health research, we 
present data in Table  4 from four leading global health 
funding bodies provided to each country: the European 
Commission, the Medical Research Council, the National 
Institutes of Health, and the Wellcome Trust [30].
As shown, the external research funding in Kenya and 
Uganda from these agencies is comparatively higher 
than for Botswana and Zambia.
While these indicators provide a static snapshot of 
some of the inputs and outputs for HSciR in the four 
countries, on their own they cannot capture the research 
governance systems underpinning knowledge produc-
tion. In this paper we aim to identify and explore some of 
the key governance elements and functions of NHRS in 
our case study countries. The paper draws on both docu-
ment review to map governance elements, and qualita-
tive research to help explain differences in performance 
and to draw lessons from their experiences in developing 
governance of NHRS and promoting HSciR.
Methods
Data were collected in 2019 through a combination of 
document analysis and semi-structured interviews. We 
aimed to both identify the governance structures and 
policies in place in each country, and then to explore 
what has supported or challenged the strengthening 
of HSciR capacity in these countries. For each case, we 
collected data sequentially from documents and then 
key informants. In terms of documentary analysis, we 
reviewed the scientific and grey literature, policy docu-
ments and websites of HSciR institutions to identify 
the HSciR actors and to inventory the HSciR policies 
and governance mechanisms. Documents for each case 
were identified through searches of scientific databases, 
Google Scholar and websites of government agencies 
(i.e., ministries of health, education, development and 
science; national research authorities; public health insti-
tutes) and research institutions. We looked for literature 
and other documents that would provide details about 
key policies, institutions, stakeholders and context of 
HSciR in each country. Documents were analysed by two 
of the case investigators (the same ones who conducted 
the fieldwork) to outline the policy and institutional land-
scape for HSciR and identify key stakeholders—namely, 
to describe and contextualize health research governance 
in each case. The contents of the documents were not 
included in the thematic analysis, but rather served to 
inform a mapping and brief description of the policy, reg-
ulatory and institutional frameworks for health research 
governance in each case.
Drawing from the documentary analysis, a stakeholder 
mapping was conducted in cooperation with local col-
laborators to identify potential informants in key organi-
zations, whom we invited to participate in the study. 
Additional names were identified through snowball sam-
pling of key informants. Key informants were from gov-
ernment ministries (health, education and/or science), 
universities, regulatory bodies, national and interna-
tional funders, public and private research institutions, 
Table 4 Funding awarded to researchers in each country (2008–2017, in 2017 US$)
Research funding institutions’ websites
Figures reported in this table are in 2017 US dollars based on consumer price index adjustments to account for inflation. Cells with no data (–) represent no funding 
from these organizations, as we excluded funding for research projects in which the principal investigators were based at non-African institutions, even if these 
projects included collaborators, field sites or locations of research in Africa
Country Wellcome Trust (United 
Kingdom-based)
United Kingdom Medical 
Research Council
United States National 
Institutes of Health
European Commission
Botswana 184,186.00 – 7,356,998.00 –
Kenya 120,959,548.23 762,618.20 23,965,606.00 2,532,293.26
Uganda 17,943,085.72 40,607,133.72 35,999,665.00 17,641.05
Zambia 15,720.00 – 13,073,179.00 –
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international organizations and nongovernmental organ-
izations involved in HSciR. Across the four countries, 
we conducted 80 interviews with key informants from 
institutions that fund, conduct and/or govern HSciR in 
the countries (summary in Table 5). An interview guide 
was developed which included key themes of investment, 
funding mechanisms, enabling environments, capac-
ity and sustainability of HSciR in African countries (see 
Additional file 1 for interview guide). Interviews focused 
on participants’ experience in carrying out research, or 
in governing or regulating HSciR. We particularly aimed 
to identify the facilitators and barriers or other factors 
that influence HSciR work, policies and regulatory prac-
tices in place to support such work, and the challenges in 
improving HSciR governance in their country. Interview-
ees were provided with information sheets and provided 
informed consent for interviews and their recording. 
Research ethics approvals and national research approv-
als were obtained from relevant ethics review boards of 
each country, as well as ethical approval from the London 
School of Economics and Political Science (see details 
under Declarations/Ethics approval).
All fieldwork for this paper was led and conducted 
in each country by two of the authors. Interviews were 
conducted in English1 by members of the research team 
based in Kenya and Uganda. For Kenya and Uganda, 
interviews were conducted by the team member for 
whom it was their home country, while field visits were 
undertaken to conduct interviews in Botswana and 
Zambia, working closely with local research collabora-
tors (also two of the authors). The research team, includ-
ing case investigators conducting interviews, consisted 
of members based in several African countries and the 
United Kingdom. All had social science and/or public 
health backgrounds, with previous research experience 
and training in qualitative research methods.
As noted, this analysis represents one arm of a larger 
study focusing on strengthening capacity for HSciR in 
Africa more broadly. Interview data were transcribed 
and imported into Dedoose software for thematic cod-
ing, focusing in particular on those governance elements 
which appeared to explain HSciR performance, strength-
ening or barriers in each setting. The data were coded 
thematically and semantically independently by research 
team members using a collaboratively developed coding 
framework based on the key themes of capacity, gov-
ernance and context, and several other specific themes 
(e.g. advocacy, alignment, partnership, funding, leader-
ship). The thematic framework was co-produced by the 
research team through an inductive approach based on 
key themes arising from key informant interviews from 
the ensemble of the fieldwork (across all nine cases in the 
larger project). Collectively, the research team further 
revised and refined the framework in response to feed-
back on provisional coding [31] and team moderation on 
a sample of data to identify differences in understanding 
and applying the codes and the identification of addi-
tional themes emerging from analysis of the first half of 
the data (through both remote discussions and a 3-day 
face-to-face analysis meeting). Upon completion of data 
collection and coding of the full qualitative interview 
data set, the research team held nine virtual meetings 
over 4 months to discuss findings and interpretations of 
data written up by each case investigator as case studies 
of what supports the development and strengthening of 
NHRS in Africa. These meetings served to support a crit-
ical approach to the replication in analysis for each case, 
which is recommended to support trustworthiness of 
claims in multiple-case replication research design [32].
For this paper we analysed the data coded under a gov-
ernance category of the larger coding framework for the 
project as a whole (see Additional file  2 for the coding 
grid). Codes in the governance category included poli-
cies, regulation, legislation and institutions. We coded 
the data structurally to categorize the interview con-
tent wherein informants discussed these concepts [31]. 
To comparatively analyse this data, we looked for what 
researchers, funders and decision-makers in the four 
countries saw as key elements of health research gov-
ernance at the national level according to their perspec-
tives, and we questioned why and how these were seen 
to be particularly important as governance functions to 
strengthen the NHRS.
Results
We first present a mapping of key policies and institu-
tions for health research governance identified in our 
case study countries—from documents reviewed and 
including when these were identified by key informants. 
Table 5 Study participants categorized by their role in the NHRS
Participant category Botswana Kenya Uganda Zambia Total
Regulator/decision 
maker
1 4 6 5 16
Researchers 17 17 7 12 53
Donors 0 4 3 4 11
Total 18 25 16 21 80
1 The information and consent form were translated and available in Setswana 
for participants in Botswana, and participants were offered the opportunity to 
have the interview in Setswana, as per national ethical guidance.
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Table 6 below gives these details in terms of the legisla-
tion, policies, institutions with governance mandates, 
and the systems for ethical governance.
Key emergent governance themes
While our interviews asked questions about what sup-
ports and facilitates strengthening HSciR and the per-
sonal experiences of individuals involved in both research 
and government working to build research capacity, we 
identified four key themes that emerged from our analy-
sis which we focus on in these results. All four of these 
themes are captured in the frameworks summarized in 
Table  1 above; however, these particular themes were 
chosen because they emerged from the analysis as the 
key processes that mattered most to stakeholders for 
strengthening and reforming governance that would ben-
efit the NHRS as a whole. This section presents insights 
and challenges according to four themes in health 
research governance that we found in our interview data 
which are part of those commonly identified core ele-
ments in the reviews of conceptual frameworks above. 
They included legislation, coordination, regulation and 
prioritization.
Prioritization of HSciR
A first point that emerged from the analysis is the impor-
tance of ensuring that health research aligns with local 
needs. Participants in all the countries raised a general 
concern that their governments had not done enough in 
shaping national health research priorities and consulting 
in-country stakeholders. Many informants mentioned 
that the HSciR agenda is often imported from interna-
tional organizations or from foreign research and funding 
institutions. This may distort research focus on external 
priorities when local needs may be different, as explained 
by a researcher from Kenya.
The global health agenda is decided at high level, 
like WHO assemblies. Most researchers tend to 
respond to the recommendations at that level, which 
[…] poses a challenge because locally we may have 
priorities that don’t fit into the global and are some-
times ignored. K17
Each country has attempted to address this in differ-
ent ways with different structures. In Kenya and Uganda, 
institutions in the science, technology and innovation 
(STI) sector have led health research prioritization pro-
cesses. While the health sector institutions in both coun-
tries also conduct similar processes in parallel, there 
has been little coordination and integration of health 
research prioritization efforts between the two sectors. In 
Zambia there is a much longer history of health research 
priority-setting by health sector institutions than in 
the other three countries, with the first national health 
research agenda produced in 1999.
Stakeholder engagement is also a key challenge for pri-
ority-setting highlighted by interviewees across the coun-
tries. This is important both to define the most relevant 
health research priorities for the country and to foster 
endorsement and understanding among stakeholder of 
the priorities for their use. While there were examples of 
engagement in a number of these exercises in Zambia, 
we were not able to identify any NHRS within the coun-
tries which appeared to have solved this problem. In Bot-
swana, it also remains a point of frustration, as expressed 
by one researcher:
In my opinion, there wasn’t much consultation in 
developing the [health research] agenda. If we had 
more consultation to develop that, then maybe we 
[could] say, "Yes, this is what the country needs." But 
I think it was sort of one-sided thing. B10
Including stakeholders in establishing national health 
research priorities was seen as important for capturing 
local concerns. However, it was also seen as important 
for facilitating the research itself, by ensuring research 
undertaken in local areas was accepted as important by 
the communities. For instance, the strategic research 
areas in Zambia have facilitated researchers’ entry to 
communities in regions which are difficult to access for 
data collection because of the government’s interest in 
priority questions such as understanding a high preva-
lence of tuberculosis in the regions.
We did not find any NHRS among these countries 
with arrangements for prioritization that stood out as 
exemplary which could offer lessons to others. Yet, one 
insight which emerged is that integrating responsibility 
for translating prioritization processes into institutional 
mandates appears a promising means to begin formal-
izing expectations and accountability around health 
research priorities. Informants highlighted those institu-
tional mandates—including the Uganda National Health 
Research Organization, the National Health Research 
Authority in Zambia, and the National Health Research 
Committee in Kenya—as being critical to advancing this 
function of health research governance.
Regulation of HSciR
A second element that informants highlighted was the 
importance of regulation—in particular of the ethics—
of health research. One of the main concerns noted 
for the ethical regulation of health research is whether 
there is a clear definition of the institutional mandate 
for this, and the extent of authority of regulatory bod-
ies. The ethics review systems for HSciR vary across 
the countries (see Table 6). Without a clearly mandated 
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body for the national oversight of ethical regulation, the 
fragmentation of regulatory systems for research eth-
ics can be problematic for a NHRS, according to par-
ticipants. Zambia was the only NHRS with a separate 
health sector statutory institution, the National Health 
Research Ethics Board (NHREB), that is centrally 
mandated for national oversight of ethics policies and 
guidelines. This differs from Uganda and Kenya, where 
the responsibility for regulatory oversight is carried 
out through STI regulatory institutions which accredit 
the institutional review boards (IRBs) in universities, 
research institutions or hospitals. In the case of Kenya, 
the National Bioethics Committee is also responsible 
for dispute resolution, monitoring and evaluation. Bot-
swana differs from the other cases in that ethical review 
of all health research is regulated by a committee under 
the auspices of the Health Research Unit at the Minis-
try of Health and Wellness.
The differing arrangements for ethics review and 
oversight could create a number of challenges for coor-
dination. For example, although all of these countries 
conducted ethical reviews, none of our interviewees 
identified a centralized repository for monitoring all 
health-related studies being carried out. Kenya, Uganda 
and Zambia have specific institutions mandated to 
review and approve of clinical trials specifically. How-
ever, informants noted that a registration system for all 
HSciR studies (including non-trial research) would be a 
useful resource for stakeholders and the public, and it 
could further improve oversight of health research by 
tracking research project status (i.e. ethics decisions, 
results, dissemination) over time.
Interviewees stressed the importance of legislation to 
strengthen ethical regulation. Zambia and Kenya have 
laws that provide standardized ethical codes for the 
conduct of health research, including clinical trials [33]. 
In countries without such legal protections, however, 
serious concerns could be raised. One decision-maker 
from Uganda noted a number of “black holes” for which 
there are no legal frameworks for ethical regulation, 
such as biobanking and biological material transfer of 
samples from the community. Uganda has the longest-
standing regulatory institution among the four coun-
tries, the Uganda National Council for Science and 
Technology (UNCST), which is actively advising gov-
ernment on policy and managing intellectual property 
for innovation with other departments, but the gaps in 
regulations to provide authority for institutions to reg-
ulate specific issues was highlighted by a researcher as 
follows:
Those regulations help to facilitate or to make 
the environment research friendly. Some of them 
do not exist, and yet they should be in place. As 
a country, we need to look at that area very care-
fully, what are the necessary research regulations? 
U5
Informants in Botswana relayed similar concerns, 
where despite its long history of HIV clinical trials, there 
appeared to be no legal frameworks for ethical regulation 
of research involving human participants or to protect 
intellectual property.
One of the central challenges that informants shared 
regarding regulation was the capacity issues for ethical 
review within IRBs. Participants from Zambia and Bot-
swana reported slow ethics processes due to inadequate 
reviewer capacity and limited resources to support IRBs. 
Capacity for ethical review requires specialized experts 
with knowledge of health research across disciplines, and 
compensation for time or buyouts for the participation 
of IRB members. One Zambian researcher (Z04) com-
mented that things were improving in this area with the 
NHREB but that “we still have a long way to go”. Inform-
ants relayed that training of committee members in sci-
entific and ethical review and monitoring of studies with 
a variety of research designs and methods (including, but 
not limited to, clinical trials) to improve this function of 
health research governance is currently missing.
Coordination of HSciR
Coordination emerged as a vital third element for health 
research governance, but informants raised it as a some-
what neglected aspect of health research governance, as 
most reform efforts have focused on regulation. Min-
istries of health are often the authorities with the remit 
for coordination of HSciR, and our findings indicated 
that coordination of health research can be most effec-
tive when there are designated statutory institutions with 
authority for coordination within legislation.
The situation in Zambia stands out, in that the 
National Health Research Authority (NHRA) oper-
ates as an independent body in the health sector that 
is responsible for both health research regulation and 
coordination. Local informants explained that this 
arose as a result of a long-term process of advocacy—
first by research leaders, in collaboration with inter-
national partners, encouraging the Ministry of Health 
to develop legislation on health research that would 
include coordination as a priority function of govern-
ance. This was followed by further advocacy of senior 
civil servants and policy-makers in the Ministry of 
Health to other ministries across sectors (including 
finance) to obtain sufficient budget to implement the 
statutory bodies. While it has been a long road for the 
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NHRA to come to fruition since the process began in 
1997, one Zambian researcher expressed how impor-
tant this has been:
The regulatory environment has improved tremen-
dously in 20 years, from nothing to a very rigid sys-
tem, to a system now that is trying to facilitate and 
encourage research. Z07
Although informants highlighted that dedicated statu-
tory bodies for health research governance should ensure 
that mandates include both regulation and coordina-
tion, these do not necessarily need to be carried out by 
the same institution. For instance, the Zambian experi-
ence contrasts with that of Kenya and Uganda, where the 
national STI bodies in the education sector are primarily 
responsible for the regulation of HSciR (as discussed in 
the previous section), while coordination of HSciR has 
been mandated by law to statutory bodies in the health 
sector. However, some informants mentioned that the 
ambiguity of roles and responsibilities between the STI 
institutions and the health research institutions some-
times leads to duplication of efforts or gaps in leadership. 
So, for instance, in Kenya, the National Health Research 
Committee was only established in 2019 to coordinate 
health research with stakeholders, develop research pri-
orities and advise the government on HSciR policies. A 
lack of intersectoral collaboration to regulate and coordi-
nate health research was thus a concern of many inform-
ants for those countries where governance arrangements 
were moving from regulation provided through STI insti-
tutions (under the auspices of ministries of education or 
science and technology), towards the inclusion of coordi-
nation by the ministries of health or other health sector 
institutions (see Table 6).
Many informants suggested that coordination of health 
research by the ministry of health is less than ideal for 
NHRS because a ministry’s core mission is policy-mak-
ing. There was a general sense across the countries that 
ministries of health often lack capacity to coordinate 
research stakeholders within the evaluation and plan-
ning units, where this function generally resides. Rather, 
statutory bodies, located at arm’s length from the politi-
cal arena with specialist research expertise, were seen by 
informants as being more fit for purpose. Thus, coordina-
tion was felt to be less effective when it was an additional 
or secondary responsibility of an agency, as this necessi-
tates dedicated and trained staff without competing with 
other internal organizational priorities. Coordination 
was reported as one area of governance that Botswana 
has struggled to develop and institutionalize within the 
Ministry of Health and Wellness, primarily due to a lack 
of dedicated capacity for this role. Thus, while countries 
might officially mandate coordination to key institutions, 
performance may be limited without capacity reflected in 
budgets and human resources.
Legislation for HSciR
Health research legislation is the final area of govern-
ance that emerged from the interviews as important. 
Multiple respondents highlighted legislation as the point 
where there could be an opportunity to comprehensively 
improve many of the elements of governance mentioned 
in preceding sections. Informants underlined two key 
potential benefits of legislation in particular—first, how 
it can formalize institutions and regulations, and second, 
how it can improve their harmonization.
The first key aspect is the formalization of regulation in 
a legal framework. Indeed, many informants viewed for-
mal legislation as the gold standard of regulatory practice. 
We found that many health research governance func-
tions in the included countries did indeed operate on the 
basis of norms and guidelines. Multiple informants also 
expressed the view that legal frameworks provide clar-
ity on authority and accountability mechanisms, and that 
they can offer some protection from political threats to 
the regulatory environment. Formalization of regulation 
in law can also bring high-level support for institution-
alizing governance and national ownership of the NHRS 
through parliamentary oversight, secured resources and 
defined legal status of HSciR stakeholders, practices and 
issues that can be helpful for raising awareness.
The second key aspect is the harmonization of vari-
ous regulations within law. Informants from countries 
with health research laws noted that legislation can also 
serve the purpose of clarifying the connections and 
relationships between the legacy of the STI regulatory 
institutions and the more recent health research statu-
tory bodies (see Table 6). For example, the law in Kenya 
helped to spell out the links between institutions and 
stakeholders in the regulatory environment and stream-
line the regulatory process for researchers, according to 
one decision-maker.
The Health Act tries to bring all these regulations 
dealing with research together, clinical trials being 
one. [T]here are many different laws and regulations 
that a researcher has to adhere to when they are car-
rying out research, and … one of the key complaints 
they have is that they don’t know [where] they have 
to go [for what]… NACOSTI [National Commission 
for Science, Technology and Innovation], ethics com-
mittees… K21
Thus, the experiences of countries like Zambia and 
Kenya have shown that health research legislation is 
useful for both constructing dedicated institutions and 
consolidating the rules in regulatory frameworks. But 
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informants also raised the fact that ensuring this coher-
ence so that the law covers the key issues for health 
research governance that are at stake in the countries 
(e.g. ethics, intellectual property, data sharing, biobank-
ing), as well as providing the mandate to institutions for 
health research financing, coordination and regulation, 
is a considerable challenge for the process of developing 
law.
We found that laws in Zambia and Kenya were most 
emblematic of these two key aspects and had the most 
comprehensive formal health research legislation of 
the four countries, while the draft of Botswana’s Health 
Research Bill (as of 2020) in Parliament reflects a simi-
lar comprehensive approach. Zambia appears to have 
achieved the earliest success of all four countries, being 
the first to have a national health research policy in 2010 
and a Health Research Act in 2013. This process began 
early with the formation of the National Health Research 
Advisory Committee in 1997, which gained authority as 
the proponent of health research legislation. Their suc-
cess was progressively achieved through sustained advo-
cacy and support from partners. The Zambian experience 
is unique in our case study countries in terms of having 
strategically used the support of international collabora-
tion for this.
Advocacy, however, is critical to improving regula-
tory environments for NHRS in part due to the need for 
resource allocation. One Ugandan respondent explained 
that while funders often gave money for research, they 
rarely did for regulatory development. The trajectory of 
Zambia shows how incremental change through advo-
cacy for a health research agenda, strategy, policy and 
health research governance institutions contributed to 
achieving the adoption and implementation of a com-
prehensive health research law by building support and 
coalitions over time. Key individuals (research leaders 
and policy-makers occupying senior roles in government 
and research institutions) also facilitated this at critical 
moments, shaping the policy context to build an enabling 
environment for HSciR through legislation.
Discussion
In this study the emerging governance elements from 
participants’ views and country documents reflect the 
elements identified in the existing frameworks in the 
literature regarding health research governance. While 
the emerging governance elements are similar in all the 
countries, the countries also have different approaches to 
and experiences with the governance of health research 
given their individual contexts. These countries may have 
some similar historical contexts (e.g. inheriting institu-
tions from a British colonial experience), yet they have 
differences with regard to political, economic, legal, 
educational and healthcare systems which are all part of 
the larger context for the governance of health research. 
The findings in particular highlight where countries 
have made progress, such as research legislation and 
policy development, along with areas like prioritization 
and coordination that remain areas needing ongoing 
reflection.
Through the findings we see that legislation in particu-
lar stands out as a standard to which countries aspire 
to formalize their regulatory frameworks and health 
governance arrangements, and which may help to raise 
awareness and status of HSciR issues within the broader 
regulatory environment. However, while health research 
legislation is seen as a benchmark for governance of 
NHRS, the process to develop and implement legisla-
tion is long and resource-intensive, as examples from 
our data show that this generally takes a decade or more 
to achieve. In addition, legislation is reinforced through 
health research policies and strategic plans. While this is 
the case for most countries, we observed that countries 
like Zambia developed health research policy before put-
ting legislation in place. The countries are also at various 
stages of developing research polices and plans. Another 
finding is that in some countries like Zambia and Uganda, 
the health research policies are outdated and there is 
a slow process in developing new ones. This illustrates 
that the existing research institutions and their partners 
continue to do research without guidance from national 
policies and priorities, which may negatively affect the 
alignment of research with the population health and 
health system needs.
One of the main similarities seen across our coun-
tries is the intersectoral nature of mandated authority in 
HSciR governance—although the division of responsi-
bility for HSciR governance between the education and 
health sector has evolved differently over time in each 
of the countries. We see the health sectors moving from 
being strongly regulated by the education sector to self-
regulation within either stand-alone health research 
authorities, as in the case of Zambia, to health research 
coordination units within the sector that are also respon-
sible for regulation of research in the countries. From 
the findings, there were strong impressions shared by 
informants in multiple countries that research units 
within ministries of health generally do not have suffi-
cient capacity for national oversight and coordination of 
HSciR, however, and such a role may be better suited to 
a statutory institution with technical and administrative 
expertise for this function.
There is significant effort to strengthen research 
ethics regulation in the countries, with the presence 
of ethics regulatory structures and guidelines for eth-
ics review in all four countries. The findings show 
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that countries differ in their arrangements for health 
research ethics and IRB oversight at the national level, 
whether as a statutory body for health research eth-
ics (Zambia), under the STI regulatory institution 
(Uganda and Kenya), or within the ministry of health 
(Botswana). Likewise, other sub-Saharan African 
countries including South Africa and Nigeria have 
established national ethics committees to guide the 
establishment of IRBs [34]. The main challenge is that 
IRBs are under-resourced, and the institutional capac-
ity for coordination of these regulatory bodies and 
research institutions is a persisting challenge across 
the countries.
The findings point to the gaps in research prioritiza-
tion including slow prioritization processes and lack of 
stakeholder engagement in priority-setting processes 
as a fundamental concern for how priorities are devel-
oped, defined and used. Frequently, we see prioriti-
zation as an exercise that happens on paper, without 
government or donor funding aligned with national 
health research priorities. In addition, when research-
ers use donor priorities to guide their work, they may 
risk failure to align their studies with the population 
health and health system needs. COHRED has argued 
that countries cannot steer research expenditure, pro-
mote science and innovation for health, strengthen 
health research capacity, support research institutions 
in the use of the priorities, or negotiate with partners 
for funding without clear national health research pri-
orities [11, 35]. We found that there have been various 
initiatives to support health research priority-setting 
in developing countries such as Zambia and Tanzania 
and four West African countries [8, 11], but overall 
reviews of national research priority-setting have dem-
onstrated that these processes requires political will, 
funding and a monitoring system to track progress 
[36].
Our findings also show that advocacy efforts by local 
leaders and international partners can be influential in 
efforts to strengthen HSciR governance when sustained 
over time and linked to individual NHRS needs in con-
text. Many African countries have received external 
support to strengthen their NHRS through improve-
ments in national HSciR governance including policy 
development, research coordination structures and 
capacity-building, as seen in Zambia and some West 
African countries [8, 37]. Our findings confirm the 
lessons from these initiatives that local/external advo-
cacy and international partnerships can be favour-
able for strengthening research governance. However, 
there should be national mechanisms for coordination 
of these partnerships, without which the efforts of the 
partners may not be recognized and supported.
Conclusion
Health research governance is an essential component 
of a strong heath research system as it plays vital role 
in the enabling environment for HSciR. This study has 
highlighted key lessons in strengthening research gov-
ernance in the covered countries as well as gaps to be 
addressed in order to have a strong research govern-
ance structures and mechanisms in the countries. 
This study was not designed to evaluate whether the 
improvements in national health research governance 
arrangements have directly led to increased research 
productivity. Furthermore, efforts to improve ele-
ments of HSciR governance are relatively recent in 
comparison to efforts to strengthen HSciR capacity. 
However, the international calls to improve governance 
of research is based on an assumption that over time 
improvements to health research governance can also 
shape research production and utilization when they 
are part of a systemic approach to NHRS strengthening.
We have highlighted some of the lessons and exam-
ples from countries in improving important elements 
of health research governance at the national level. 
Improving legal frameworks for the regulation, coor-
dination and prioritization of health research aligned 
with resources for effective functioning of the govern-
ance systems is integral to achieving effective and sus-
tainable NHRS that remains a goal across the African 
continent [17]. Establishing and strengthening national 
health research authorities and other statutory bod-
ies with mandates to coordinate and regulate health 
research across all research institutions and stakehold-
ers is central to this goal. Moving forward it will be 
critically important to think proactively about the gov-
ernance of HSciR to improve research outputs and use.
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